Raiffeisen Bank's stock ranking has fallen from 686 to 762 in the latest trend analysis by the BOTSI®-Advisor, which manages a model portfolio that has averaged a 27.5% annual return since 1999. The BOTSI®-Advisor focuses on the strongest trending stocks globally, offering easy replication for investors.
UBS has reduced its target price for Bechtle from 44.60 to 36 euros while maintaining a "Neutral" rating. Analyst Michael Briest noted increasing short-term headwinds, leading to a reduction in earnings estimates by up to five percent through 2026 and the removal of a previously considered valuation discount.
Glarner Kantonalbank hosted a successful pension planning event on November 14, 2024, at the lintharena in Näfels, attracting over 200 attendees. The event featured presentations from bank experts on pensions, investments, and inheritance, emphasizing the importance of careful financial planning for retirement. Participants engaged in discussions and networking over an aperitif, highlighting the relevance of the topic.
UBS has maintained its "Buy" rating for Novartis, setting a price target of 111 francs, following insights from a recent conference. CFO Harry Kirsch expressed optimism about growth prospects for 2025, coinciding with the expiration of the Entresto patent, according to analyst Matthew Weston.
UBS has maintained a "Neutral" rating for Pfizer, setting a price target of $31 following a recent conference. Analyst Trung Huynh noted that despite a mixed performance this year, the pharmaceutical company is starting to regain investor confidence.
UBS has maintained its "Buy" rating for National Grid, setting a target price of 1120 pence following a conference where CFO Andy Agg expressed a positive outlook. Analyst Mark Freshney highlighted this in a report published on November 13, 2024.
UBS has maintained its "Buy" rating for ArcelorMittal, setting a target price of €26.50 following an industry conference. Analyst Andrew Jones noted the company's commitment to disciplined capital allocation amid investor concerns regarding future investment levels.
UBS has maintained a "Sell" rating for Hapag-Lloyd, setting a target price of 106 euros following the company's third-quarter results. Analyst Cristian Nedelcu noted that Hapag-Lloyd's operating profit (EBITDA) figures exceeded market expectations, as confirmed in October.
UBS has maintained its "Buy" rating for AB InBev, setting a target price of 72 euros. Following a recent conference, analysts noted improvements in the US market and increased confidence in Latin America (excluding Mexico) and Africa, although challenges in Mexico are expected to continue.
UBS has maintained its "Buy" rating for Merck KGaA, setting a target price of 190 euros following the third quarter results. Sales met market expectations, while the adjusted EBITDA exceeded forecasts due to reduced research spending in the healthcare sector, although this trend may not continue. Overall, the results did not present any significant surprises.
Seems like the connection with the server has been lost. It can be due to poor or broken network. Please hang on while we're trying to reconnect...
Oh snap! Failed to reconnect with the server. This is typically caused by a longer network outage, or if the server has been taken down. You can try to reconnect, but if that does not work, you need to reload the page.
Oh man! The server rejected the attempt to reconnect. The only option now is to reload the page, but be prepared that it won't work, since this is typically caused by a failure on the server.
